CIK 0001816590 · Non-accelerated filer<br>Smaller reporting company
COMPASS Pathways plc
Sign in to watch- Ticker
- CMPS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 1-716-676-6461
- Business address
- 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESIRE, United Kingdom, WA14 2DT
- Former names
- Compass Rx Ltd.
- 4 Planned sale 10% owner sold 51,500 shares at $8.96 ($461,332)
- 4 Planned sale 10% owner sold 51,500 shares at $8.96 ($461,332)
- 4 Planned sale 10% owner sold 51,500 shares at $8.65 ($445,552)
- 4 Planned sale 10% owner sold 51,500 shares at $8.65 ($445,552)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Planned sale Director sold 65,886 shares at an average $10.70 ($704,821)
- 4 Planned sale Director sold 65,886 shares at an average $10.70 ($704,821)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award Chief Financial Officer acquired 62,718 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Planned sale Director sold 59,255 shares at an average $10.29 ($609,862)
- 4 Planned sale Director sold 59,255 shares at an average $10.29 ($609,862)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Planned sale Director sold 85,293 shares at an average $10.58 ($902,124)
- 4 Planned sale Director sold 85,293 shares at an average $10.58 ($902,124)
Page 8 of 18 · 344 filings